nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—CYP2B6—malignant glioma	0.651	1	CbGaD
Nevirapine—CYP1A2—Carmustine—malignant glioma	0.133	0.57	CbGbCtD
Nevirapine—CYP3A4—Temozolomide—malignant glioma	0.101	0.43	CbGbCtD
Nevirapine—Traumatic liver injury—Temozolomide—malignant glioma	0.00338	0.0544	CcSEcCtD
Nevirapine—Opportunistic infection—Temozolomide—malignant glioma	0.00313	0.0503	CcSEcCtD
Nevirapine—Transaminases increased—Carmustine—malignant glioma	0.00214	0.0345	CcSEcCtD
Nevirapine—Hepatotoxicity—Carmustine—malignant glioma	0.00169	0.0272	CcSEcCtD
Nevirapine—Necrosis—Carmustine—malignant glioma	0.00166	0.0267	CcSEcCtD
Nevirapine—Hepatotoxicity—Temozolomide—malignant glioma	0.00163	0.0263	CcSEcCtD
Nevirapine—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00153	0.0246	CcSEcCtD
Nevirapine—Liver injury—Temozolomide—malignant glioma	0.0015	0.0241	CcSEcCtD
Nevirapine—Drug interaction—Carmustine—malignant glioma	0.00141	0.0226	CcSEcCtD
Nevirapine—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00133	0.0214	CcSEcCtD
Nevirapine—Skin exfoliation—Carmustine—malignant glioma	0.00125	0.02	CcSEcCtD
Nevirapine—Skin exfoliation—Temozolomide—malignant glioma	0.0012	0.0194	CcSEcCtD
Nevirapine—Hepatic failure—Temozolomide—malignant glioma	0.00102	0.0164	CcSEcCtD
Nevirapine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00097	0.0156	CcSEcCtD
Nevirapine—Face oedema—Carmustine—malignant glioma	0.000914	0.0147	CcSEcCtD
Nevirapine—Face oedema—Temozolomide—malignant glioma	0.000884	0.0142	CcSEcCtD
Nevirapine—Liver function test abnormal—Carmustine—malignant glioma	0.000874	0.0141	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000824	0.0133	CcSEcCtD
Nevirapine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000824	0.0133	CcSEcCtD
Nevirapine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000807	0.013	CcSEcCtD
Nevirapine—Neutropenia—Carmustine—malignant glioma	0.000765	0.0123	CcSEcCtD
Nevirapine—Neutropenia—Temozolomide—malignant glioma	0.00074	0.0119	CcSEcCtD
Nevirapine—Hyperglycaemia—Carmustine—malignant glioma	0.000738	0.0119	CcSEcCtD
Nevirapine—Renal failure—Carmustine—malignant glioma	0.000717	0.0115	CcSEcCtD
Nevirapine—Neuropathy peripheral—Carmustine—malignant glioma	0.000715	0.0115	CcSEcCtD
Nevirapine—Hyperglycaemia—Temozolomide—malignant glioma	0.000714	0.0115	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000699	0.0112	CcSEcCtD
Nevirapine—Neuropathy peripheral—Temozolomide—malignant glioma	0.000691	0.0111	CcSEcCtD
Nevirapine—Hepatobiliary disease—Temozolomide—malignant glioma	0.000667	0.0107	CcSEcCtD
Nevirapine—Connective tissue disorder—Carmustine—malignant glioma	0.000644	0.0104	CcSEcCtD
Nevirapine—Hepatitis—Temozolomide—malignant glioma	0.000633	0.0102	CcSEcCtD
Nevirapine—Connective tissue disorder—Temozolomide—malignant glioma	0.000622	0.01	CcSEcCtD
Nevirapine—Erythema multiforme—Temozolomide—malignant glioma	0.000599	0.00963	CcSEcCtD
Nevirapine—Immune system disorder—Temozolomide—malignant glioma	0.000572	0.0092	CcSEcCtD
Nevirapine—Erythema—Carmustine—malignant glioma	0.00057	0.00917	CcSEcCtD
Nevirapine—Erythema—Temozolomide—malignant glioma	0.000551	0.00886	CcSEcCtD
Nevirapine—Anaemia—Carmustine—malignant glioma	0.000527	0.00848	CcSEcCtD
Nevirapine—Ill-defined disorder—Temozolomide—malignant glioma	0.000511	0.00822	CcSEcCtD
Nevirapine—Anaemia—Temozolomide—malignant glioma	0.000509	0.00819	CcSEcCtD
Nevirapine—Angioedema—Temozolomide—malignant glioma	0.000504	0.0081	CcSEcCtD
Nevirapine—Malaise—Temozolomide—malignant glioma	0.000497	0.00799	CcSEcCtD
Nevirapine—Myalgia—Carmustine—malignant glioma	0.000486	0.00781	CcSEcCtD
Nevirapine—Myalgia—Temozolomide—malignant glioma	0.000469	0.00755	CcSEcCtD
Nevirapine—Arthralgia—Temozolomide—malignant glioma	0.000469	0.00755	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000466	0.00749	CcSEcCtD
Nevirapine—Oedema—Carmustine—malignant glioma	0.000466	0.00748	CcSEcCtD
Nevirapine—Discomfort—Temozolomide—malignant glioma	0.000464	0.00745	CcSEcCtD
Nevirapine—Thrombocytopenia—Carmustine—malignant glioma	0.000456	0.00733	CcSEcCtD
Nevirapine—Anaphylactic shock—Temozolomide—malignant glioma	0.00045	0.00723	CcSEcCtD
Nevirapine—Oedema—Temozolomide—malignant glioma	0.00045	0.00723	CcSEcCtD
Nevirapine—Anorexia—Carmustine—malignant glioma	0.000444	0.00713	CcSEcCtD
Nevirapine—Nervous system disorder—Temozolomide—malignant glioma	0.000441	0.00709	CcSEcCtD
Nevirapine—Thrombocytopenia—Temozolomide—malignant glioma	0.00044	0.00708	CcSEcCtD
Nevirapine—Skin disorder—Temozolomide—malignant glioma	0.000437	0.00703	CcSEcCtD
Nevirapine—Anorexia—Temozolomide—malignant glioma	0.000429	0.00689	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000424	0.00682	CcSEcCtD
Nevirapine—Paraesthesia—Carmustine—malignant glioma	0.000418	0.00672	CcSEcCtD
Nevirapine—Somnolence—Carmustine—malignant glioma	0.000414	0.00665	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00041	0.00659	CcSEcCtD
Nevirapine—Decreased appetite—Carmustine—malignant glioma	0.000405	0.00651	CcSEcCtD
Nevirapine—Paraesthesia—Temozolomide—malignant glioma	0.000404	0.00649	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000402	0.00646	CcSEcCtD
Nevirapine—Somnolence—Temozolomide—malignant glioma	0.0004	0.00643	CcSEcCtD
Nevirapine—Pain—Carmustine—malignant glioma	0.000398	0.0064	CcSEcCtD
Nevirapine—Decreased appetite—Temozolomide—malignant glioma	0.000391	0.00629	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000388	0.00624	CcSEcCtD
Nevirapine—Fatigue—Temozolomide—malignant glioma	0.000388	0.00624	CcSEcCtD
Nevirapine—Pain—Temozolomide—malignant glioma	0.000385	0.00619	CcSEcCtD
Nevirapine—Feeling abnormal—Carmustine—malignant glioma	0.000384	0.00617	CcSEcCtD
Nevirapine—Gastrointestinal pain—Carmustine—malignant glioma	0.000381	0.00612	CcSEcCtD
Nevirapine—Feeling abnormal—Temozolomide—malignant glioma	0.000371	0.00596	CcSEcCtD
Nevirapine—Body temperature increased—Carmustine—malignant glioma	0.000368	0.00592	CcSEcCtD
Nevirapine—Abdominal pain—Carmustine—malignant glioma	0.000368	0.00592	CcSEcCtD
Nevirapine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000368	0.00591	CcSEcCtD
Nevirapine—Urticaria—Temozolomide—malignant glioma	0.000357	0.00575	CcSEcCtD
Nevirapine—Abdominal pain—Temozolomide—malignant glioma	0.000356	0.00572	CcSEcCtD
Nevirapine—Body temperature increased—Temozolomide—malignant glioma	0.000356	0.00572	CcSEcCtD
Nevirapine—Hypersensitivity—Carmustine—malignant glioma	0.000343	0.00551	CcSEcCtD
Nevirapine—Asthenia—Carmustine—malignant glioma	0.000334	0.00537	CcSEcCtD
Nevirapine—Hypersensitivity—Temozolomide—malignant glioma	0.000331	0.00533	CcSEcCtD
Nevirapine—Asthenia—Temozolomide—malignant glioma	0.000323	0.00519	CcSEcCtD
Nevirapine—Diarrhoea—Carmustine—malignant glioma	0.000319	0.00512	CcSEcCtD
Nevirapine—Pruritus—Temozolomide—malignant glioma	0.000318	0.00512	CcSEcCtD
Nevirapine—Diarrhoea—Temozolomide—malignant glioma	0.000308	0.00495	CcSEcCtD
Nevirapine—Vomiting—Carmustine—malignant glioma	0.000296	0.00476	CcSEcCtD
Nevirapine—Rash—Carmustine—malignant glioma	0.000294	0.00472	CcSEcCtD
Nevirapine—Dermatitis—Carmustine—malignant glioma	0.000293	0.00471	CcSEcCtD
Nevirapine—Headache—Carmustine—malignant glioma	0.000292	0.00469	CcSEcCtD
Nevirapine—Vomiting—Temozolomide—malignant glioma	0.000286	0.0046	CcSEcCtD
Nevirapine—Rash—Temozolomide—malignant glioma	0.000284	0.00456	CcSEcCtD
Nevirapine—Dermatitis—Temozolomide—malignant glioma	0.000283	0.00456	CcSEcCtD
Nevirapine—Headache—Temozolomide—malignant glioma	0.000282	0.00453	CcSEcCtD
Nevirapine—Nausea—Carmustine—malignant glioma	0.000277	0.00445	CcSEcCtD
Nevirapine—Nausea—Temozolomide—malignant glioma	0.000267	0.0043	CcSEcCtD
Nevirapine—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	8.69e-05	0.00165	CbGpPWpGaD
Nevirapine—CYP2D6—Metapathway biotransformation—CYP2C18—malignant glioma	8.65e-05	0.00164	CbGpPWpGaD
Nevirapine—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	8.57e-05	0.00163	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—CYP2B6—malignant glioma	8.57e-05	0.00163	CbGpPWpGaD
Nevirapine—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	8.45e-05	0.0016	CbGpPWpGaD
Nevirapine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	8.18e-05	0.00155	CbGpPWpGaD
Nevirapine—CYP2A6—NRF2 pathway—PDGFB—malignant glioma	7.9e-05	0.0015	CbGpPWpGaD
Nevirapine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	7.74e-05	0.00147	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	7.43e-05	0.00141	CbGpPWpGaD
Nevirapine—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	7.33e-05	0.00139	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—RTEL1—malignant glioma	7.15e-05	0.00136	CbGpPWpGaD
Nevirapine—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	7.12e-05	0.00135	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—GSTT1—malignant glioma	7.09e-05	0.00135	CbGpPWpGaD
Nevirapine—CYP2B6—Biological oxidations—GSTP1—malignant glioma	7.07e-05	0.00134	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—GSTT1—malignant glioma	7.03e-05	0.00133	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—RTEL1—malignant glioma	6.99e-05	0.00133	CbGpPWpGaD
Nevirapine—CYP2B6—Metapathway biotransformation—GSTP1—malignant glioma	6.98e-05	0.00132	CbGpPWpGaD
Nevirapine—CYP3A5—Biological oxidations—GSTP1—malignant glioma	6.91e-05	0.00131	CbGpPWpGaD
Nevirapine—CYP3A5—Metapathway biotransformation—GSTP1—malignant glioma	6.82e-05	0.00129	CbGpPWpGaD
Nevirapine—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	6.78e-05	0.00129	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—PTGS1—malignant glioma	6.65e-05	0.00126	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	6.61e-05	0.00126	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—PTGS1—malignant glioma	6.59e-05	0.00125	CbGpPWpGaD
Nevirapine—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	6.52e-05	0.00124	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	6.46e-05	0.00123	CbGpPWpGaD
Nevirapine—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	6.43e-05	0.00122	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	6.41e-05	0.00122	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	6.2e-05	0.00118	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—GSTT1—malignant glioma	6.01e-05	0.00114	CbGpPWpGaD
Nevirapine—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	5.8e-05	0.0011	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	5.77e-05	0.00109	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	5.74e-05	0.00109	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	5.73e-05	0.00109	CbGpPWpGaD
Nevirapine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	5.65e-05	0.00107	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—PTGS1—malignant glioma	5.63e-05	0.00107	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—COX8A—malignant glioma	5.09e-05	0.000967	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—RTEL1—malignant glioma	4.97e-05	0.000944	CbGpPWpGaD
Nevirapine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	4.96e-05	0.000942	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—RTEL1—malignant glioma	4.93e-05	0.000936	CbGpPWpGaD
Nevirapine—CYP2D6—Biological oxidations—GSTP1—malignant glioma	4.92e-05	0.000933	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	4.88e-05	0.000927	CbGpPWpGaD
Nevirapine—CYP2C9—Biological oxidations—GSTP1—malignant glioma	4.87e-05	0.000925	CbGpPWpGaD
Nevirapine—CYP2D6—Metapathway biotransformation—GSTP1—malignant glioma	4.85e-05	0.000921	CbGpPWpGaD
Nevirapine—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	4.81e-05	0.000913	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	4.64e-05	0.00088	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	4.49e-05	0.000853	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	4.39e-05	0.000834	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	4.39e-05	0.000834	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	4.34e-05	0.000825	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—ASMT—malignant glioma	4.33e-05	0.000822	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—RTEL1—malignant glioma	4.21e-05	0.000799	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	4.18e-05	0.000794	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	4.18e-05	0.000794	CbGpPWpGaD
Nevirapine—CYP1A2—Biological oxidations—GSTP1—malignant glioma	4.16e-05	0.000791	CbGpPWpGaD
Nevirapine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	4.15e-05	0.000788	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—COX8A—malignant glioma	4.11e-05	0.00078	CbGpPWpGaD
Nevirapine—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	4.11e-05	0.00078	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—BCAN—malignant glioma	4.07e-05	0.000773	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—COX8A—malignant glioma	4.01e-05	0.000762	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.52e-05	0.000669	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—ASMT—malignant glioma	3.49e-05	0.000663	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—ASMT—malignant glioma	3.41e-05	0.000648	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.41e-05	0.000647	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—BCAN—malignant glioma	3.28e-05	0.000623	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—IDH2—malignant glioma	3.28e-05	0.000623	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—RTEL1—malignant glioma	3.25e-05	0.000617	CbGpPWpGaD
Nevirapine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	3.21e-05	0.00061	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—BCAN—malignant glioma	3.21e-05	0.000609	CbGpPWpGaD
Nevirapine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	3.17e-05	0.000602	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYP2B6—malignant glioma	3.08e-05	0.000586	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.01e-05	0.000571	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	2.91e-05	0.000553	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—COX8A—malignant glioma	2.85e-05	0.000542	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—COX8A—malignant glioma	2.83e-05	0.000537	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—IDH1—malignant glioma	2.82e-05	0.000536	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—SPHK1—malignant glioma	2.73e-05	0.000518	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CYP2C18—malignant glioma	2.67e-05	0.000508	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—IDH2—malignant glioma	2.65e-05	0.000503	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—IDH2—malignant glioma	2.59e-05	0.000491	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.53e-05	0.00048	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP2B6—malignant glioma	2.43e-05	0.000462	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—ASMT—malignant glioma	2.43e-05	0.000461	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—COX8A—malignant glioma	2.42e-05	0.000459	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—ASMT—malignant glioma	2.41e-05	0.000457	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.35e-05	0.000447	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—BCAN—malignant glioma	2.28e-05	0.000433	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—IDH1—malignant glioma	2.28e-05	0.000432	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—BCAN—malignant glioma	2.26e-05	0.00043	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—IDH1—malignant glioma	2.22e-05	0.000422	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—SPHK1—malignant glioma	2.2e-05	0.000418	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTT1—malignant glioma	2.16e-05	0.000411	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.16e-05	0.00041	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CYP2C18—malignant glioma	2.16e-05	0.00041	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—SPHK1—malignant glioma	2.15e-05	0.000409	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CYP2C18—malignant glioma	2.11e-05	0.0004	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—ASMT—malignant glioma	2.06e-05	0.00039	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS1—malignant glioma	2.03e-05	0.000385	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.01e-05	0.000382	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—BCAN—malignant glioma	1.93e-05	0.000367	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—BCHE—malignant glioma	1.88e-05	0.000358	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—COX8A—malignant glioma	1.87e-05	0.000354	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—SLC5A5—malignant glioma	1.86e-05	0.000353	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—IDH2—malignant glioma	1.84e-05	0.000349	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—IDH2—malignant glioma	1.82e-05	0.000346	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTT1—malignant glioma	1.74e-05	0.000331	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.73e-05	0.000328	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.72e-05	0.000327	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.71e-05	0.000326	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTT1—malignant glioma	1.71e-05	0.000324	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS1—malignant glioma	1.64e-05	0.00031	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS1—malignant glioma	1.6e-05	0.000303	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—ASMT—malignant glioma	1.59e-05	0.000301	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—IDH1—malignant glioma	1.58e-05	0.0003	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—IDH1—malignant glioma	1.57e-05	0.000298	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—IDH2—malignant glioma	1.56e-05	0.000296	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SPHK1—malignant glioma	1.53e-05	0.000291	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—BCHE—malignant glioma	1.52e-05	0.000289	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SPHK1—malignant glioma	1.52e-05	0.000288	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.5e-05	0.000285	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.5e-05	0.000285	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—GSTP1—malignant glioma	1.5e-05	0.000285	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—BCAN—malignant glioma	1.49e-05	0.000283	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.49e-05	0.000282	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—BCHE—malignant glioma	1.49e-05	0.000282	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.47e-05	0.000279	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—SLC5A5—malignant glioma	1.47e-05	0.000279	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.47e-05	0.000278	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CAT—malignant glioma	1.46e-05	0.000277	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.4e-05	0.000266	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—NCOR1—malignant glioma	1.38e-05	0.000262	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—IDH1—malignant glioma	1.34e-05	0.000254	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SPHK1—malignant glioma	1.3e-05	0.000246	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.28e-05	0.000242	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.27e-05	0.000241	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.23e-05	0.000234	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTT1—malignant glioma	1.21e-05	0.00023	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—GSTP1—malignant glioma	1.21e-05	0.00023	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—IDH2—malignant glioma	1.2e-05	0.000228	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTT1—malignant glioma	1.2e-05	0.000228	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.2e-05	0.000227	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—GSTP1—malignant glioma	1.18e-05	0.000224	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CAT—malignant glioma	1.18e-05	0.000223	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CAT—malignant glioma	1.15e-05	0.000218	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS1—malignant glioma	1.14e-05	0.000216	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.13e-05	0.000215	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS1—malignant glioma	1.13e-05	0.000214	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—CAV1—malignant glioma	1.12e-05	0.000213	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.12e-05	0.000213	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—NCOR1—malignant glioma	1.11e-05	0.000211	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.09e-05	0.000207	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—NCOR1—malignant glioma	1.09e-05	0.000206	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—BCHE—malignant glioma	1.06e-05	0.000201	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.05e-05	0.0002	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—BCHE—malignant glioma	1.05e-05	0.000199	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.04e-05	0.000198	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.03e-05	0.000196	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—IDH1—malignant glioma	1.03e-05	0.000196	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTT1—malignant glioma	1.03e-05	0.000195	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CG—malignant glioma	1.02e-05	0.000194	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SPHK1—malignant glioma	1e-05	0.00019	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PPARG—malignant glioma	9.87e-06	0.000187	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CYP2C18—malignant glioma	9.8e-06	0.000186	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.78e-06	0.000186	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.69e-06	0.000184	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS1—malignant glioma	9.63e-06	0.000183	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.59e-06	0.000182	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—CAV1—malignant glioma	9.06e-06	0.000172	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CD—malignant glioma	8.99e-06	0.000171	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—BCHE—malignant glioma	8.95e-06	0.00017	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—CAV1—malignant glioma	8.86e-06	0.000168	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—SLC5A5—malignant glioma	8.84e-06	0.000168	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.45e-06	0.000161	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—GSTP1—malignant glioma	8.41e-06	0.00016	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.36e-06	0.000159	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—GSTP1—malignant glioma	8.33e-06	0.000158	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.28e-06	0.000157	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CG—malignant glioma	8.25e-06	0.000157	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CAT—malignant glioma	8.18e-06	0.000155	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CAT—malignant glioma	8.11e-06	0.000154	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CG—malignant glioma	8.07e-06	0.000153	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PPARG—malignant glioma	7.97e-06	0.000151	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTT1—malignant glioma	7.93e-06	0.000151	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CB—malignant glioma	7.84e-06	0.000149	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PPARG—malignant glioma	7.79e-06	0.000148	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTGS2—malignant glioma	7.77e-06	0.000147	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—NCOR1—malignant glioma	7.73e-06	0.000147	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—NCOR1—malignant glioma	7.66e-06	0.000145	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS1—malignant glioma	7.43e-06	0.000141	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CD—malignant glioma	7.26e-06	0.000138	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.22e-06	0.000137	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—GSTP1—malignant glioma	7.12e-06	0.000135	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CD—malignant glioma	7.09e-06	0.000135	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CAT—malignant glioma	6.93e-06	0.000132	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—BCHE—malignant glioma	6.91e-06	0.000131	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—SLC5A5—malignant glioma	6.82e-06	0.00013	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PTEN—malignant glioma	6.77e-06	0.000129	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—NCOR1—malignant glioma	6.54e-06	0.000124	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CB—malignant glioma	6.32e-06	0.00012	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—CAV1—malignant glioma	6.3e-06	0.00012	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTGS2—malignant glioma	6.27e-06	0.000119	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—CAV1—malignant glioma	6.24e-06	0.000119	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CB—malignant glioma	6.18e-06	0.000117	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTGS2—malignant glioma	6.12e-06	0.000116	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.96e-06	0.000113	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CG—malignant glioma	5.74e-06	0.000109	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CG—malignant glioma	5.69e-06	0.000108	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PPARG—malignant glioma	5.54e-06	0.000105	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—GSTP1—malignant glioma	5.5e-06	0.000104	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PPARG—malignant glioma	5.49e-06	0.000104	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PTEN—malignant glioma	5.46e-06	0.000104	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CAT—malignant glioma	5.35e-06	0.000102	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PTEN—malignant glioma	5.34e-06	0.000101	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—CAV1—malignant glioma	5.33e-06	0.000101	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.1e-06	9.68e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—NCOR1—malignant glioma	5.05e-06	9.59e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CD—malignant glioma	5.04e-06	9.57e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CD—malignant glioma	5e-06	9.49e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CG—malignant glioma	4.86e-06	9.23e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—PIK3CA—malignant glioma	4.78e-06	9.07e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PPARG—malignant glioma	4.69e-06	8.91e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.4e-06	8.35e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.36e-06	8.27e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTGS2—malignant glioma	4.36e-06	8.27e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTGS2—malignant glioma	4.32e-06	8.2e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CD—malignant glioma	4.27e-06	8.11e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—CAV1—malignant glioma	4.12e-06	7.82e-05	CbGpPWpGaD
Nevirapine—CYP2A6—Metabolism—AKT1—malignant glioma	3.9e-06	7.41e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.86e-06	7.32e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PTEN—malignant glioma	3.8e-06	7.21e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—PIK3CA—malignant glioma	3.77e-06	7.15e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PTEN—malignant glioma	3.77e-06	7.15e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.75e-06	7.12e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.72e-06	7.07e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTGS2—malignant glioma	3.69e-06	7.01e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PPARG—malignant glioma	3.62e-06	6.87e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.3e-06	6.26e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PTEN—malignant glioma	3.22e-06	6.11e-05	CbGpPWpGaD
Nevirapine—CYP2B6—Metabolism—AKT1—malignant glioma	3.15e-06	5.98e-05	CbGpPWpGaD
Nevirapine—CYP3A5—Metabolism—AKT1—malignant glioma	3.08e-06	5.84e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.87e-06	5.46e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTGS2—malignant glioma	2.85e-06	5.41e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.68e-06	5.09e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.66e-06	5.04e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PTEN—malignant glioma	2.48e-06	4.71e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.27e-06	4.31e-05	CbGpPWpGaD
Nevirapine—CYP2D6—Metabolism—AKT1—malignant glioma	2.19e-06	4.16e-05	CbGpPWpGaD
Nevirapine—CYP2C9—Metabolism—AKT1—malignant glioma	2.17e-06	4.12e-05	CbGpPWpGaD
Nevirapine—CYP1A2—Metabolism—AKT1—malignant glioma	1.85e-06	3.52e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.75e-06	3.33e-05	CbGpPWpGaD
Nevirapine—CYP3A4—Metabolism—AKT1—malignant glioma	1.43e-06	2.72e-05	CbGpPWpGaD
